In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 23.2 | 15.6 | 20.3 | 7.2 |
Revenue growth | 48.7% | -23.3% | 181.9% | |
Cost of goods sold | 9.9 | 16.3 | 17.6 | 8.1 |
Gross profit | 13.2 | -0.7 | 2.7 | -0.9 |
Gross margin | 57.1% | -4.5% | 13.5% | -11.9% |
Selling, general and administrative | 73.1 | 48.5 | 13.6 | 9.8 |
Research and development | | 10.8 | 4.4 | 2.9 |
General and administrative | | 1.0 | | |
EBITA | -59.9 | -58.6 | -15.3 | -13.6 |
EBITA margin | -258.1% | -375.4% | -75.2% | -188.1% |
Amortization of intangibles | | 0.3 | | |
EBIT | -59.9 | -58.9 | -15.3 | -13.6 |
EBIT margin | -258.1% | -377.4% | -75.2% | -188.1% |
Pre-tax income | -52.7 | 28.8 | -60.6 | -14.9 |
Income taxes | 40.1 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | 0.0% | 0.0% |
Earnings from continuing ops | -52.7 | 28.8 | -60.6 | -14.9 |
Earnings from discontinued ops | -40.1 | | | |
Net income | -92.8 | 28.8 | -60.6 | -14.9 |
Net margin | -400.1% | 184.6% | -298.0% | -206.5% |
|
Diluted EPS | ($0.37) | $0.19 | ($0.72) | ($0.19) |
Shares outstanding (diluted) | 142.7 | 148.5 | 84.6 | 79.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |